Johnson & Johnson (J&J) Pacific and its creative agencies are still awaiting news as to how or if J&J's global review and consolidation of creative accounts will affect the Australian market.
The global consolidation was announced overnight in a statement and comes in the wake of the appointment of a new global marketing and PR boss, Michael Sneed, in December.
"Johnson & Johnson is conducting a global agency review and consolidation to build greater value and deliver innovative and fully integrated solutions for our consumer brands,” said a report in AdAge.
How the global pitch will affect the FMCG giant's Australian arm and its creative agencies is yet to be revealed by J&J's head office. J&J Pacific told to AdNews it was not sure how the changes will impact the Australian market although there will possibly be a trickle-down effect.
“We are not aware of any changes occurring to our advertising and marketing roster in the near future in Australia,” a Johnson & Johnson spokesperson said.
J&J Pacific currently works with creative agencies including DDB, JWT and 303Lowe.
DDB handles brands including Nutrogena and Aveno while JWT works on Regaine and Nicorette.
303Lowe handles J&J's feminine hygine product portfolio which includes Carefree and was behind the infamous “vagina” ad currently in the headlines.
The global creative review follows a media agency review J&J launched for its Europe, Middle East and Africa markets earlier this year.
Have something to say on this? Share your views in the comments section below. Or if you have a news story or tip-off, drop us a line at firstname.lastname@example.org